Clinical Trial Update: A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout [Phase 2]

View source ↗

Summary

Phase 2 trial update for AC-201 controlled-release tablet in gout has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• AC-201

Snippet

Sponsor: TWi Biotechnology, Inc. | Conditions: Gout | Phase 2 | Status: COMPLETED | Results posted: 2020-10-28